Skip to search formSkip to main contentSkip to account menu

Budesonide 0.125 MG/ML Inhalant Solution [Pulmicort]

Known as: BUDESONIDE 0.25 mg in 2 mL RESPIRATORY (INHALATION) SUSPENSION [PULMICORT RESPULES], Pulmicort Respules 0.125 MG/ACTUAT Inhalant Solution, Pulmicort Respules 0.25 MG per 2 ML Inhalant Suspension 
National Institutes of Health

Related topics

Related topics

10 relations
BudesonideBudesonide 0.25 MG/ML Inhalant Solution [Pulmicort]Citric Acid, AnhydrousEdetic Acid, Disodium Salt

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Observation on the clinical effects of the atomizing inhalation of ventolinum,atrovent and pulmicore respules on bronchiolitis.
Objective To investigate the clinical effects of ventolinum,atrovent and pulmicore respules in atomizing inhalation on… 
2005
2005
Observation on the Clinical Effects of the Atomizing Inhalation of Combivent and Pulmicore Respules on Bronchiolitis
  • Lu Bo
  • 2005
  • Corpus ID: 75327635
Objective To investigate the clinical effects of combivent and pulmicore respules in atomizinginhalation on bronchiolitis.Methods… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)